drugset / Trial / NCT00537342

Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT)

NCT00537342 ↗

Phase 3 Completed 83 enrolled Laboratorios Leti, S.L.
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this trial is to evaluate the clinical effectiveness of the administration of a depigmented and polymerized allergen extract of Olea europaea in the rhinitis or allergic rhinoconjunctivitis

Timeline

Start
2007-10
Primary completion
2009-09
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject modified extract of O. europaea pollen Vaccine — Other

Indications